At Patients Choice Laboratories we are pioneering new ways to provide patient care. By delivering physicians with the most precise testing and industry leading robust reporting, patients and providers now have a real choice for diagnostic services.
We specialize in toxicology and molecular diagnostics that provide precise and specific results allowing for quick diagnoses and treatment of patients. We provide expert testing in the areas of Toxicology, Infectious Disease, Pharmacogenetics and Antibiotic Resistance.
Forward Thinking-
At PCL we are dedicated to staying on the forefront of medical diagnostics and providing the most comprehensive and innovative testing available to ensure the health of our communities now and into the future.
|
|
|
|
|
11-50 employees
View all Patients Choice Laboratories employees
|
|
|
Hospital & Health Care
|
|
|
$10M–$50M
|
|
|
833-569-0440
|
|
|
7026 Corporate Drive, Indianapolis, IN 46278, US
|
|
|
2013
|
|
|
Personalized Medicine, Women's Health, Molecular Diagnostics, Infectious Disease, Toxicology, Pharmacogenetics, Antibiotic Resistance, Uti, Confirmation Testing, Covid Testing, Respiratory Pathogen Testing
|
The decision makers in Patients Choice Laboratories are Jerome Nypaver, Nick Petrillo, Rojeet Shrestha, etc. Click to Find Patients Choice Laboratories decision makers emails.
Patients Choice Laboratories headquarters is located at 7026 Corporate Drive, Indianapolis, IN 46278, US.
Patients Choice Laboratories generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Patients Choice Laboratories by calling 833-569-0440.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.